The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study
Status:
Not yet recruiting
Trial end date:
2025-08-01
Target enrollment:
Participant gender:
Summary
A phase II randomized, double-blind, placebo-controlled clinical trial (RCT) to evaluate the
ability of zonisamide (ZON) to decrease alcohol use among treatment-seeking adults with an
alcohol use disorder (AUD).